Cyclic peptide compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8603975
APP PUB NO 20100120672A1
SERIAL NO

12598404

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a new cyclic peptide compound or a salt thereof, which has anti-hepatitis C virus activities based on inhibitory activity against the RNA replication of hepatitis C virus replicon, a process for preparation thereof, a pharmaceutical composition comprising the same, and a method for prophylactic and/or therapeutic treatment of hepatitis C in a human being or an animal.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ASTELLAS PHARMA INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Harayama, Yu Tokyo, JP 3 0
Ishida, Junya Tokyo, JP 23 134
Kunikawa, Shigeki Tokyo, JP 8 86
Makino, Takuya Tokyo, JP 36 224
Mizuno, Hiroaki Osaka, JP 48 253
Ohki, Hidenori Tokyo, JP 18 210
Ohtake, Hiroaki Osaka, JP 7 101
Toda, Ayako Tokyo, JP 9 84
Yamanaka, Toshio Tokyo, JP 84 845

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 10, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00